Author

Fanmuyi Yang

Cincinnati Children's Hospital Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Anil Goud JeggaiD· 1 shared Anjaparavanda P. NareniD· 1 shared Daisuke KiharaiD· 1 shared Jing CheniD· 1 shared Kavisha AroraiD· 1 shared Woong‐Hee ShiniD· 1 shared Yunguan WangiD· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Anil Goud JeggaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PP-2, a src-kinase inhibitor, is a potential corrector for F508del-CFTR in cystic fibrosis

Yunguan Wang, Kavisha Arora, Fanmuyi Yang, Woong‐Hee Shin, Jing Chen, Daisuke Kihara, Anjaparavanda P. Naren, Anil Goud Jegga

The paper identifies PP-2, a src-kinase inhibitor, as a novel corrector for ΔF508-CFTR in cystic fibrosis through in silico screening and experimental validation.

bioRxiv · Mar 24, 2018 · PreprintSystems Biology